Dr. Bryan Patenaude, an assistant professor in the department of international health at the Johns Hopkins Bloomberg School of Public Health, was named to Forbes 30 under 30 list in the health care field. The annual list recognizes the achievements of young leaders and innovators across 20 categories. Dr. Patenaude, a health care economist, was honored for his work examining the most effective interventions to prevent and treat disease and disability.
Dr. Patenaude currently leads the Decade of Vaccine Economics (DOVE) project based at the International Vaccine Access Center in the Bloomberg School’s department of international health. The project aims to quantify the return-on-investment of vaccines, globally. The estimates from this project have been used to inform the Gavi investment case, which showcases impact and value of the vaccines that are made available to countries through its vaccine support programs. Dr. Patenaude has also been awarded a grant by the Bill & Melinda Gates Foundation for the project “Vaccine Economics Research for Sustainability and Equity (VERSE)” from 2020 – 2023 to continue examining the sustainability and equity of vaccine investments.
The Forbes 30 Under 30 list Class of 2020 includes 30 honorees in 20 categories. Nearly 20,000 nominations were received and evaluated by a wide range of reporters and judges, including Rear Admiral Denise Hinton, the FDA’s chief scientist, for the health care category.Friday Letter Submission, Publish on December 13